Panpan Chen
Impact in
- Geriatrics and Gerontology top 2%
- Sirtuins and Resveratrol in Medicine
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Epidemiology 12
- Autophagy in Disease and Therapy 7
- Co-authors
- Haolin Chen (10 shared papers)Barry R. Zirkin (5 shared papers)Hui Jin (3 shared papers)Yuliang Zhao (2 shared papers)Lei Wang (1 shared paper)Guoliang Cui (1 shared paper)Guoqing Zhao (1 shared paper)Minjie Li (2 shared papers)
- Journals
- Molecular and Cellular Endocrinology (4 papers)Blood (3 papers)Environmental Pollution (2 papers)Acta Pharmaceutica Sinica B (2 papers)International Journal of Biological Macromolecules (2 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Panpan Chen
96 papers receiving 1.9k citations
Panpan Chen's Hit Papers
Peers
Comparison fields: 5 of 126
- Geriatrics and Gerontology 92
- Infectious Diseases 329
- Reproductive Medicine 105
- Cancer Research 177
- Genetics 116
Countries citing papers authored by Panpan Chen
This map shows the geographic impact of Panpan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panpan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panpan Chen more than expected).
Fields of papers citing papers by Panpan Chen
This network shows the impact of papers produced by Panpan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panpan Chen. The network helps show where Panpan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Panpan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial Hit paper breakdown → | 2021 | 370 |
| 2 | 2014 | 97 | |
| 3 | 2020 | 91 | |
| 4 | 2019 | 80 | |
| 5 | 2014 | 59 | |
| 6 | 2018 | 49 | |
| 7 | 2018 | 45 | |
| 8 | 2020 | 42 | |
| 9 | 2018 | 37 | |
| 10 | 2020 | 37 | |
| 11 | 2016 | 36 | |
| 12 | 2022 | 36 | |
| 13 | 2014 | 35 | |
| 14 | 2017 | 35 | |
| 15 | 2023 | 30 | |
| 16 | 2020 | 29 | |
| 17 | 2022 | 29 | |
| 18 | 2018 | 28 | |
| 19 | 2019 | 26 | |
| 20 | 2020 | 25 |
About Panpan Chen
Panpan Chen is a scholar working on Molecular Biology, Epidemiology, Cancer Research, Surgery and Oncology, having authored 104 papers that have together received 1.9k indexed citations. Recurring topics across this work include Sperm and Testicular Function (10 papers), Autophagy in Disease and Therapy (7 papers), CAR-T cell therapy research (6 papers), Liver physiology and pathology (5 papers), Cancer-related molecular mechanisms research (5 papers), Effects and risks of endocrine disrupting chemicals (5 papers), MicroRNA in disease regulation (5 papers) and Testicular diseases and treatments (5 papers). The work is most often cited by research in Geriatrics and Gerontology (92 citations), Infectious Diseases (329 citations), Reproductive Medicine (105 citations), Cancer Research (177 citations) and Genetics (116 citations). Panpan Chen has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Haolin Chen, Barry R. Zirkin, Hui Jin, Yuliang Zhao, Lei Wang, Guoliang Cui, Guoqing Zhao, Minjie Li, Zhiwei Wu and Wanqi Yang. Their work appears in journals such as Molecular and Cellular Endocrinology, Blood, Environmental Pollution, Acta Pharmaceutica Sinica B and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.